Interestingly, several studies have demonstrated that patients with alpha-synucleinopaties (PD and multiple system atrophy-MSA) presented constitutionally reduced levels of anti-antibodies against alpha-synuclein, indicating how an impairment of immune functioning may predispose to these neurodegenerative diseases [11]. This evidence concerns the gene SNCA and Parkinson disease.